Scarica l'app Stockscreener
3.90
0.64%
-0.025
Dopo l'orario di chiusura:
3.84
-0.06
-1.54%
Precedente Chiudi:
$3.925
Aprire:
$3.82
Volume 24 ore:
633.16K
Relative Volume:
3.11
Capitalizzazione di mercato:
$276.29M
Reddito:
-
Utile/perdita netta:
$-2.97M
Rapporto P/E:
-3.9474
EPS:
-0.988
Flusso di cassa netto:
$-1.18M
1 W Prestazione:
+6.27%
1M Prestazione:
+55.69%
6M Prestazione:
-49.13%
1 anno Prestazione:
-76.21%
Intervallo 1D:
$3.7289
$4.3097
Intervallo di 1 settimana:
$3.29
$4.4999
Portata 52W:
$1.70
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
3.90 | 278.06M | 0 | -2.97M | -1.18M | -0.988 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Yd Bio Ltd Borsa (YDES) Ultime notizie
Unusual volume stocks are being observed in Thursday's session. - ChartMill
Unusual volume stocks in Tuesday's session - ChartMill
YD Bio Ord Shs (YDES) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com
YD Bio posts $6.7M profit but flags going concern | YDES SEC FilingForm 6-K - Stock Titan
YD Bio H1FY26 Results: Revenue up 315%, net profit turns positive - scanx.trade
YD Bio Limited Reports First-Half 2026 Financial Results, 315% Revenue Growth and Net Income of $6.7 Million - quiverquant.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
YD Bio's New Review Connects Omega-3, Vitamins D3 and K2 to Heart, Brain and Bone - Stock Titan
ETFs Investing in YD Bio Limited Stocks - TradingView
Top movers in Tuesday's pre-market session - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
After-Hours Gainers: PFSA Executes Another Reverse Split, IVF Jumps On Q2 Results, AMLX Faces D-Day - RTTNews
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
YD Bio Ord Shs (YDES) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
YD Bio Launches Physician-Led Nutraceuticals in Taiwan to Build Consumer Health Ecosystem - TipRanks
YD Bio launches nutrition products via physician partnership model By Investing.com - Investing.com Australia
YD Bio launches nutrition products via physician partnership model - Investing.com
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future Health Institute - Yahoo Finance
YD Bio Limited (YDES) unveils Taiwan physician-partnership nutraceutical strategy - Stock Titan
Top YD Bio (YDES) Competitors 2026 - MarketBeat
YD Bio Ord Shs (YDES) Stock News Today - TradingKey
Lantheus Holdings (LNTH) Holds Near $101 as Buyers Defend Key SupportForce Index - vinanet.vn
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research - Yahoo Finance
YD Bio Launches Cross-Border Cancer Testing Pilot in Canada - Clinical Lab Products
YD Bio Warrants (YDESW) Hold Steady at $0.25 as Tight Range Caps GainsFloat Adjusted Cap - dars.gov.et
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada - The Manila Times
YD Bio launches pilot for cancer testing in British Columbia By Investing.com - Investing.com Canada
Five Cancer Types Targeted in YD Bio's Cross-Border Pilot - Stock Titan
Y.D. More group (TATT) reports 5.42% beneficial stake in TAT Technologies - Stock Titan
YD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
YD Bio Ord Shs (YDES) Cash Flow - TradingKey
YDES|YD Bio Ord Shs|Price:2.350|Chg%:+0.110 - TradingKey
YD Bio Ord Shs (YDES) Balance Sheet - TradingKey
YDES|YD Bio Ord Shs|Price:2.300|Chg%:-0.020 - TradingKey
YD Bio Ord Shs (YDES) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
YD Bio Ord Shs (YDES) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
YD Bio Ord Shs (YDES) Institutional Confidence - TradingKey
YD Bio Ord Shs (YDES) Risk Assessment: Volatility, Financial Risk & Investment Risk - tradingkey.com
YD Bio Ord Shs (YDES) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
YDES|YD Bio Ord Shs|Price:2.240|Chg%:+0.200 - TradingKey
YD Bio Ord Shs (YDES) Income Statement - TradingKey
YD Bio Limited (YDES) Surges 7.7% as Shares Test Key Resistance at $2.35Statistical Arbitrage - dars.gov.et
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
30 Prospective Partners Explore Cancer Tests and Eye Care at Taiwan Expo - Stock Titan
Diabetic Macular Edema Pipeline 2026: MOA, ROA, FDA-Approved - openPR.com
Gapping stocks in Wednesday's session - ChartMill
YDESW Warrants Surge 6.67%: Key Levels and Technical Outlook for YD Bio Limited WarrantsCollar Trade - dars.gov.et
Enterprise value to revenue forward of YD Bio Limited – NASDAQ:YDES - TradingView
Enterprise value to EBIT forward of YD Bio Limited – NASDAQ:YDES - TradingView
PLPC Q1 2026 Earnings: EPS Surprises to the Upside, but Stock DeclinesAnnual Report - dars.gov.et
Yd Bio Ltd Azioni (YDES) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):